In the BioHarmony Drug Report Database
Ansuvimab
Ebanga (ansuvimab) is an antibody pharmaceutical. Ansuvimab was first approved as Ebanga on 2020-12-21.
Trade Name
|
Ebanga |
|---|---|
Common Name
|
ansuvimab |
ChEMBL ID
|
CHEMBL4594388 |
Indication
|
|
Drug Class
|
Monoclonal antibodies: viruses, antiviral indications |
Image (chem structure or protein)
